Hartford Business, 1/27/2025, Lamont says his budget will raise R&D tax credit to 90%, asks bioscience execs for help with drug prices, https://cutt.ly/Oe40Z6xu
AJMC, 6/19/2024, Part 2: Unlocking the Potential of Biosimilars to Improve Health Equity, https://cutt.ly/ieaoqSDy
AJMC, 5/7/2024, Part 1: Unlocking the Potential of Biosimilars to Improve Health Equity, https://cutt.ly/Terteg6e
WSJ, 4/29/2024, Coming to a CVS Near You: A Store Brand Monoclonal Antibody https://cutt.ly/geqjTaoj
Creaky Joints, 7/8/2022, Warning: Your Health Insurance Might Not Cover the Meds You Need Most, https://cutt.ly/42N9Hgp
Pharmacy Today, 7/7/2022, Pharmacists’ expanded scope of practice here to stay?
American Journal of Managed Care, 6/28/2022, Mental Health, Immunizations, Sleep Focus of Barriers in Prevention and High-Value Care, https://cutt.ly/Y2N9Pp5
Infectious Disease Advisor, 5/27/2022, The Case for Expanding Pharmacists’ Authority to Administer Vaccines, https://cutt.ly/c2N9U91
Pharmacy Today, 3/1/2022, Most physicians unable to estimate patients’ out-of-pocket costs: How pharmacists can help
The Center for Biosimilars, 1/12/2022, Biosimilar Progress and Education in the United States, https://cutt.ly/XIpqoxL
Pink Sheet, 2/21/2011, Lobbying Around State eRx Legislation Pits Payers Against Manufacturers
The Grand Rapids Press, 3/9/2008, Health plans push harder for use of generic drugs, not as 'equivalents' but as 'alternatives', https://cutt.ly/E2N2bSK
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.